Influence of Monopoly Game on Subtle Behaviors

September 13, 2019 updated by: University of Florida

The Effects of Experimentally Manipulated Social Status on Energy Balance in Youth: A Randomized Controlled Trial

The purpose of this research study is to investigate how social standing in a game of Monopoly may influence behavior.

Study Overview

Detailed Description

Participants will be asked to fill out questionnaires/surveys and health measures will be collected throughout the study visit. These health measures will include: blood pressure, heart rate, height/weight, waist circumference, percent body fat, resting metabolic rate, and salivary cortisol. Breakfast will be provided and then a 40-minute game of Monopoly™ will be played, and lunch will be provided after the game. Participants will be given an accelerometer to measure movements, and a food diary to be used for a 24-hour period. Once the 24-hour monitoring period has been completed, the participants will be finished with the study activities. The accelerometer and food diary will be returned by either bringing them to the investigators or mailing the items back to the investigators.

Study Type

Interventional

Enrollment (Actual)

133

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32610
        • University of Florida Clinical Translational Science Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 21 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Hispanic American adolescents born in the United States
  • Have played Monopoly before

Exclusion Criteria:

  • Clinical depression
  • A diagnosis of cardiovascular disease (active or within the past 6 months), cancer (active or within the past 2 years, except non-melanoma skin cancer), diabetes (type 1 or 2), active or chronic infections, gastrointestinal disease, active kidney disease, lung disease, uncontrolled psychiatric disease
  • An eating disorder or severely restricted diet
  • Use of tobacco products
  • Substance abuse disorder
  • Take any medications known to affect appetite or body composition
  • Participation in any weight-reduction programs, weight-loss diets, or other special diets within the previous 3 months
  • Experience of weight loss or gain of 10 pounds or more of body weight in the past 6 months for any reason except post-partum weight loss
  • Current/Anticipation of pregnancy during study
  • Currently nursing or within 6 weeks of having completed nursing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Social Status Condition
Participants will be provided with a high degree of privilege in a game of Monopoly.
Participants will be provided with a high degree of privilege in a game of Monopoly.
Experimental: Low Social Status Condition
Participants will be provided with a low degree of privilege in a game of Monopoly.
Participants will be provided with a low degree of privilege in a game of Monopoly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Energy balance between the groups at hour 4 and over 24 hours
Time Frame: Hour 4, After 24 Hours
The investigators will assess energy balance using accelerometry, consumption data and resting metabolic rate.
Hour 4, After 24 Hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in blood pressure between the groups at hours 0, 1, 3, 4
Time Frame: Hours 0, 1, 3, 4
Systolic and diastolic blood pressure will be assessed.
Hours 0, 1, 3, 4
Change in heart rate between the groups at hours 0, 1, 3, 4
Time Frame: Hours 0, 1, 3, 4
Heart rate will be captured using a heart rate monitor.
Hours 0, 1, 3, 4
Change in salivary cortisol between the groups at hours 1, 3
Time Frame: Hours 1, 3
Salivary cortisol will be collected and tested to determine objective stress levels.
Hours 1, 3
Change in Visual Analog Scales (VAS) between the groups at hours 0, 1, 3, 4
Time Frame: Hours 0, 1, 3, 4
Scores are from 0 - 100, 0 generally meaning least and 100 generally meaning most.
Hours 0, 1, 3, 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michelle I Cardel, PhD, RD, University of Florida

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

July 7, 2018

Study Completion (Actual)

July 7, 2018

Study Registration Dates

First Submitted

March 31, 2016

First Submitted That Met QC Criteria

March 31, 2016

First Posted (Estimate)

April 6, 2016

Study Record Updates

Last Update Posted (Actual)

September 17, 2019

Last Update Submitted That Met QC Criteria

September 13, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB201600361

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Disease

Clinical Trials on High Social Status Condition

3
Subscribe